PRLHR and Alzheimer disease: Namely, PRLHR methylation was increased in both low [median = 18.93% (IQR = 16.24–23.06)] and intermediate [median = 17.32% (IQR = 15.20–18.37)] AD patients with respect to controls (p-value < 0.01, for both comparisons) (Figure 1C).